Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.020 CAD
−4.57 M CAD
1.07 M CAD
225.30 M
About THERALASE TECHNOLOGIES INC
Sector
Industry
CEO
Roger J. Dumoulin-White
Website
Headquarters
Toronto
Founded
1989
FIGI
BBG000BDZ9K8
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TLT is 0.290 CAD — it has increased by 1.75% in the past 24 hours. Watch THERALASE TECHNOLOGIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange THERALASE TECHNOLOGIES INC stocks are traded under the ticker TLT.
TLT stock has risen by 3.57% compared to the previous week, the month change is a −15.94% fall, over the last year THERALASE TECHNOLOGIES INC has showed a 61.11% increase.
TLT stock is 1.75% volatile and has beta coefficient of −1.60. Track THERALASE TECHNOLOGIES INC stock price on the chart and check out the list of the most volatile stocks — is THERALASE TECHNOLOGIES INC there?
Yes, you can track THERALASE TECHNOLOGIES INC financials in yearly and quarterly reports right on TradingView.
THERALASE TECHNOLOGIES INC is going to release the next earnings report on Nov 28, 2024. Keep track of upcoming events with our Earnings Calendar.
TLT net income for the last quarter is −1.13 M CAD, while the quarter before that showed −1.27 M CAD of net income which accounts for 10.50% change. Track more THERALASE TECHNOLOGIES INC financial stats to get the full picture.
No, TLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THERALASE TECHNOLOGIES INC EBITDA is −4.15 M CAD, and current EBITDA margin is −402.51%. See more stats in THERALASE TECHNOLOGIES INC financial statements.
Like other stocks, TLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THERALASE TECHNOLOGIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THERALASE TECHNOLOGIES INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THERALASE TECHNOLOGIES INC stock shows the buy signal. See more of THERALASE TECHNOLOGIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.